Elakkad et al. demonstrated that simvastatin-loaded cubosomes significantly reduced the levels of anti-apoptotic Bcl-2 protein, GSH, and GPX4 in breast cancer cells while markedly increasing ROS and lipid peroxide levels [60]. Here, BCL2 is linked to breast carcinoma.